NCT07633262 FACE-APPS-Based Approach for Improving Iron Deficiency Anaemia Indicators Among Female Adolescents at Marginalized Communities
| NCT ID | NCT07633262 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Cairo University |
| Condition | Iron Deficiency Anemia |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2026-05-24 |
| Primary Completion | 2026-11-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2026-05-24 with a primary completion date of 2026-11-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study aims to evaluate the effect of the Face-to-face Assisted Counselling with Enhanced Application School-Based Approach (FACE-APPS-Based Approach) on anemia indicators among female adolescents. The study is a prospective, randomized controlled trial. A total of 160 female adolescents with hemoglobin levels below 12.0 g/dL will be recruited from 7 secondary schools. Random assignment at the individual level, stratified by baseline anemia status, will be used to ensure balance. For participants in the intervention group, the intervention will be designed by an interdisciplinary team and administered over 4 months, comprising 8 face-to-face counseling sessions and 8 parallel mobile application modules. Control group participants will receive standard care (diagnosis and referral). The primary outcomes are the mean differences in hemoglobin and serum ferritin levels. Secondary outcomes are engagement among female adolescents (attendance at counseling sessions and completion of mobile application modules).
Eligibility Criteria
Inclusion Criteria: * Adolescent females aged 14-17 years * who are attending high school * who have haemoglobin levels \<12 mg/dl and serum ferritin levels below 15 μg/L Exclusion Criteria: * Adolescents have other causes of anemia, such as thalassemia and sickle cell anemia, and malaria will be excluded. * Adolescents with chronic diseases that affect iron metabolism (e.g., chronic kidney disease) or other severe illnesses or conditions that may interfere with active participation. * Pregnant females will be excluded (if included in the age group). * Adolescents with gastrointestinal ulcers, colon polyps, or cancers; celiac disease; Crohn's disease; or gastric bypass surgery.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07633262 clinical trial?
This trial is open to female participants only, aged 14 Years or older, up to 14 Years, studying Iron Deficiency Anemia. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07633262 currently recruiting?
Yes, NCT07633262 is actively recruiting participants. Contact the research team at mr.mash87@cu.edu.eg for enrollment information.
Where is the NCT07633262 trial being conducted?
This trial is being conducted at Wadi Addawasir, Saudi Arabia.
Who is sponsoring the NCT07633262 clinical trial?
NCT07633262 is sponsored by Cairo University. The trial plans to enroll 160 participants.